original ) (raw )Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy
JACK CHAN
Molecular Neurobiology, 2018
View PDFchevron_right
Pharmacogenomics of chemotherapy induced cognitive dysfunction
Rowan Ejielat
View PDFchevron_right
An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study
Han Kiat Ho
Scientific Reports
View PDFchevron_right
Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study
Han Kiat Ho
BMC cancer, 2017
View PDFchevron_right
Genetic variants associated with longitudinal cognitive performance in older breast cancer patients and controls
Brenna McDonald
medRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function
Philippe Robaey
NeuroReport, 2000
View PDFchevron_right
Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study
Georges Chahine
BMC Cancer, 2022
View PDFchevron_right
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment
Breno Satler
World Journal of Biological Psychiatry, 2010
View PDFchevron_right
Genetic risk factors for cancer-related cognitive impairment: a systematic review
Ali Amidi
Acta Oncologica
View PDFchevron_right
BDNF Val66Met polymorphism and memory performance in older adults: the Met carrier effect is more complex than previously thought
Tatiana De Nardi
Revista Brasileira de Psiquiatria, 2017
View PDFchevron_right
Additive effect of BDNF and REST polymorphisms is associated with improved general cognitive ability
Antony Payton
Genes, Brain and Behavior, 2008
View PDFchevron_right
Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly
Alan Jackson
Genes, Brain and Behavior, 2008
View PDFchevron_right
A Functional Polymorphism (rs6265, G>A) of Brain-Derived Neurotrophic Factor Gene and Breast Cancer: An Association Study
Mehir Iqbal
Breast Cancer: Basic and Clinical Research, 2019
View PDFchevron_right
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors
Priscilla McAuliffe
Breast cancer (Dove Medical Press), 2017
View PDFchevron_right
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Prediction of Neural Risk for Alzheimer Disease
Claire Lusk
Archives of General Psychiatry, 2011
View PDFchevron_right
A Systematic Review Focusing on Understanding the Effects of a Defined Set of Non-Modifiable Factors in Patients who Suffer from Chemotherapy Induced Cognitive Impairments or “Chemobrain”
Saba Sharafkhaneh
Research Square (Research Square), 2024
View PDFchevron_right
BDNF gene polymorphisms and haplotypes in relation to cognitive performance in Polish healthy subjects
Ludmiła Zając-Lamparska
View PDFchevron_right
Brain derived neurotrophic factor (BDNF) polymorphisms and memory in healthy adults with university education
Miguel A Alvarez
Psicológica, 2023
View PDFchevron_right
Title: Genetic Susceptibility to Neurocognitive Impairment Secondary to Childhood Cancer Treatment Working Group: Genetics Psychology Investigators
Melissa Hudson
2019
View PDFchevron_right
An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
Kenneth Usuki
Seminars in Oncology, 2011
View PDFchevron_right
A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer
Haryana Dhillon
View PDFchevron_right
Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study
Chau Dang
Breast Diseases: A Year Book Quarterly, 2007
View PDFchevron_right
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimerʼs disease
Xiantong Zhen
Neuroreport, 2010
View PDFchevron_right
Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments
Freya J Saykin
Current psychiatry …, 2004
View PDFchevron_right
Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions
Andy Roth
Palliative and Supportive Care, 2007
View PDFchevron_right
Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy
Pim Brouwers
Pediatric Blood & Cancer, 2011
View PDFchevron_right
Chemotherapy-Induced Cognitive Impairment in Women With Breast Cancer: A Critique of the Literature
Rasha Said
Oncology Nursing Forum, 2005
View PDFchevron_right
Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment
Vojtěch Kaplan
Journal of Alzheimer's Disease, 2020
View PDFchevron_right
Cognitive dysfunction and cancer: which consequences in terms of disease management?
Benedicte Giffard
Psycho-oncology, 2011
View PDFchevron_right
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia
Philippe Robaey
Journal of Clinical Oncology, 2015
View PDFchevron_right
Brain-derived neurotrophic factor Val66Met polymorphism, human memory, and synaptic neuroplasticity
Karen Waldie
Wiley Interdisciplinary Reviews: Cognitive Science, 2014
View PDFchevron_right
BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade glioma
Sofia Kakaizada
Neuro-Oncology Practice, 2019
View PDFchevron_right